{"id":26678,"date":"2025-03-13T10:55:35","date_gmt":"2025-03-13T09:55:35","guid":{"rendered":"https:\/\/www.unither-pharma.com\/developpement-dun-nouveau-vaccin-prophylactique\/"},"modified":"2026-03-31T19:07:59","modified_gmt":"2026-03-31T17:07:59","slug":"developpement-dun-nouveau-vaccin-prophylactique","status":"publish","type":"post","link":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/","title":{"rendered":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique"},"content":{"rendered":"<p><strong>ONCOVITA et UNITHER Pharmaceuticals s\u2019associent pour le d\u00e9veloppement d\u2019un nouveau vaccin prophylactique bas\u00e9 sur les technologies Measovir\u00ae et Euroject\u00ae<\/strong><\/p>\n<p><strong>Paris, 13 mars 2025 \u2013<\/strong> ONCOVITA, soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de vaccins innovants, spin off de l\u2019Institut Pasteur, et UNITHER Pharmaceuticals, leader mondial dans la fabrication d\u2019unidoses st\u00e9riles, annoncent leur partenariat strat\u00e9gique pour le d\u00e9veloppement et la production d\u2019un nouveau vaccin combin\u00e9 prophylactique dans la pr\u00e9vention de maladies infectieuses chez l\u2019enfant.<\/p>\n<p>Cette collaboration associe Measovir\u00ae, la plateforme technologique d\u2019ONCOVITA permettant la conception de vaccins hautement immunog\u00e8nes, \u00e0 Euroject\u00ae, le dispositif d\u2019UNITHER Pharmaceuticals bas\u00e9 sur la technologie Blow-Fill-Seal (BFS), con\u00e7u pour l\u2019injection directe en unidose de vaccins et de produits biologiques. Ensemble, ces technologies visent \u00e0 offrir une solution efficace, \u00e9conomique et accessible, adapt\u00e9e \u00e0 une production \u00e0 grande \u00e9chelle.<\/p>\n<p>\u00ab <em>Nous concevons des vaccins innovants gr\u00e2ce \u00e0 une technologie de rupture, avec pour ambition une preuve de concept chez l\u2019homme, puis d\u2019amener ces avanc\u00e9es jusqu\u2019au chevet des patients en partenariat avec des industriels. Ce partenariat avec Unither nous permet d\u2019explorer l\u2019int\u00e9gration de Measovir\u00ae et Euroject\u00ae pour une administration simplifi\u00e9e d\u2019un vaccin sur base d\u2019une souche vivante att\u00e9nu\u00e9e de la rougeole. Notre objectif : une solution efficace, s\u00fbre et facile \u00e0 d\u00e9ployer pour mieux prot\u00e9ger les patients \u00e0 l\u2019\u00e9chelle mondiale<\/em> \u00bb, d\u00e9clare le Dr. Jean-Fran\u00e7ois Le Bigot, Pr\u00e9sident d\u2019ONCOVITA.<\/p>\n<p>\u00ab <em>Nous sommes convaincus que l\u2019association de la technologie Measovir\u00ae et du dispositif Euroject\u00ae constitue une avanc\u00e9e majeure pour rendre la vaccination plus simple, s\u00fbre et efficace \u00e0 grande \u00e9chelle. En facilitant l\u2019administration des vaccins et en optimisant leur accessibilit\u00e9, nous contribuons \u00e0 am\u00e9liorer et simplifier la vie des patients et \u00e0 r\u00e9pondre aux grands enjeux de sant\u00e9 publique d\u2019aujourd\u2019hui et de demain.<\/em> \u00bb, indique Eric Goupil, Pr\u00e9sident d\u2019Unither Pharmaceuticals.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>A propos de Measovir\u00ae<\/strong><\/p>\n<p>La technologie Measovir\u00ae repose sur une souche att\u00e9nu\u00e9e du virus de la rougeole, utilis\u00e9e depuis plus de 50 ans dans la vaccination avec un excellent profil de s\u00e9curit\u00e9. Cette plateforme \u00ab plug-and-play \u00bb permet l\u2019insertion de g\u00e8nes sp\u00e9cifiques d\u2019autres agents pathog\u00e8nes, transformant le virus vaccinal de la rougeole en un vecteur capable d\u2019induire une r\u00e9ponse immunitaire robuste et durable contre diverses maladies infectieuses. Elle se distingue par sa forte capacit\u00e9 \u00e0 activer les d\u00e9fenses immunitaires inn\u00e9es et adaptatives, garantissant ainsi un haut niveau d\u2019efficacit\u00e9 et de s\u00e9curit\u00e9.<\/p>\n<p><strong>A propos d\u2019Euroject<\/strong>\u00ae<\/p>\n<p>Euroject\u00ae est un dispositif innovant bas\u00e9 sur la technologie Blow-Fill-Seal (BFS) pour l&rsquo;injection en unidose de produits th\u00e9rapeutiques. Cette unidose pr\u00e9remplie permet une administration simple, s\u00fbre et \u00e9conomique des vaccins, r\u00e9duisant ainsi les co\u00fbts et facilitant la logistique de vaccination \u00e0 large \u00e9chelle. Un b\u00e2timent d\u00e9di\u00e9 sur le site d\u2019Unither \u00e0 Amiens \u00e9quip\u00e9e de cinq lignes de remplissage, permettra de produire plus d\u2019un milliard de doses par an.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>A propos d\u2019Oncovita<\/strong><\/p>\n<p>Oncovita, spin off de l\u2019Institut Pasteur, est une soci\u00e9t\u00e9 de biotechnologie d\u00e9di\u00e9e \u00e0 la conception et au d\u00e9veloppement pr\u00e9coce de nouveaux vaccins th\u00e9rapeutiques et prophylactiques pour lutter contre diff\u00e9rents types de cancers et de maladies infectieuses. Ses candidats vaccins sont mis au point en utilisant une plateforme technologique innovante propri\u00e9taire, Measovir\u00ae qui permet de modifier le g\u00e9nome du virus vaccinal de la rougeole. Parmi les candidats con\u00e7us avec cette plateforme \u00ab plug- and-play \u00bb figurent un virus oncolytique, MVdeltaC \u00e0 forte activit\u00e9 apoptotique immunog\u00e8ne (tumeurs solides) ainsi que plusieurs vaccins prophylactiques combin\u00e9s contre des maladies infectieuses. La mission d\u2019Oncovita est de d\u00e9velopper ses candidats depuis la phase pr\u00e9clinique jusqu\u2019\u00e0 la preuve de concept clinique. Oncovita a \u00e9t\u00e9 laur\u00e9ate du programme \u00ab\u00a0Innovations en bioth\u00e9rapies et bioproduction\u00a0\u00bb du plan Innovation Sant\u00e9 France 2030.<\/p>\n<p><a href=\"https:\/\/www.oncovita.fr\">https:\/\/www.oncovita.fr<\/a><\/p>\n<p><strong>\u00c0 propos d\u2019Unither Pharmaceuticals<\/strong><\/p>\n<p>Unither Pharmaceuticals est un sous-traitant pharmaceutique sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et la fabrication de formulations liquides en unidoses et multidoses (notamment des collyres, des solutions salines, des m\u00e9dicaments pour l\u2019asthme en unidoses BFS et des sticks oraux) pour les laboratoires pharmaceutiques innovants et fabricants de g\u00e9n\u00e9riques. Avec 2300 employ\u00e9s et huit sites de production en France, aux \u00c9tats-Unis, au Br\u00e9sil et en Chine, ainsi qu\u2019un centre R&amp;D en France, Unither Pharmaceuticals a r\u00e9alis\u00e9 un chiffre d\u2019affaires de 522 millions d\u2019euros en 2024.<\/p>\n<p><a href=\"http:\/\/www.unither-pharma.com\">www.unither-pharma.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Contacts presse\u00a0:<\/strong><\/p>\n<p>Unither Pharmaceuticals : Elisabeth ALIDOU, <a href=\"mailto:contact@unither-pharma.com\">contact@unither-pharma.com<\/a><\/p>\n<p>Oncovita : <a href=\"mailto:contact@oncovita.fr\">contact@oncovita.fr<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ONCOVITA et UNITHER Pharmaceuticals s\u2019associent pour le d\u00e9veloppement d\u2019un nouveau vaccin prophylactique bas\u00e9 sur les technologies Measovir\u00ae et Euroject\u00ae Paris, 13 mars 2025 \u2013 ONCOVITA, soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de vaccins innovants, spin off de l\u2019Institut Pasteur, et UNITHER Pharmaceuticals, leader mondial dans la fabrication d\u2019unidoses st\u00e9riles, annoncent leur partenariat strat\u00e9gique pour [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":20110,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19,209],"tags":[],"class_list":["post-26678","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-communique-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither<\/title>\n<meta name=\"description\" content=\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither\" \/>\n<meta property=\"og:description\" content=\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\" \/>\n<meta property=\"og:site_name\" content=\"Unither\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-13T09:55:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-31T17:07:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:site\" content=\"@UnitherPharma\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28\"},\"headline\":\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique\",\"datePublished\":\"2025-03-13T09:55:35+00:00\",\"dateModified\":\"2026-03-31T17:07:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\"},\"wordCount\":782,\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\",\"name\":\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg\",\"datePublished\":\"2025-03-13T09:55:35+00:00\",\"dateModified\":\"2026-03-31T17:07:59+00:00\",\"description\":\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unither-pharma.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"name\":\"Unither\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\",\"name\":\"Unither\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"width\":514,\"height\":252,\"caption\":\"Unither\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/UnitherPharma\",\"https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/\",\"https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28\",\"name\":\"admin\",\"sameAs\":[\"https:\/\/www.unither-pharma.com\"],\"url\":\"https:\/\/www.unither-pharma.com\/fr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither","description":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither","og_description":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither","og_url":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/","og_site_name":"Unither","article_published_time":"2025-03-13T09:55:35+00:00","article_modified_time":"2026-03-31T17:07:59+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@UnitherPharma","twitter_site":"@UnitherPharma","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#article","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/"},"author":{"name":"admin","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28"},"headline":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique","datePublished":"2025-03-13T09:55:35+00:00","dateModified":"2026-03-31T17:07:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/"},"wordCount":782,"publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg","articleSection":["Actualit\u00e9s","Communiqu\u00e9 de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/","url":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/","name":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg","datePublished":"2025-03-13T09:55:35+00:00","dateModified":"2026-03-31T17:07:59+00:00","description":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique | Unither","breadcrumb":{"@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#primaryimage","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/03\/ONCOVITA_UNITHER.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/www.unither-pharma.com\/fr\/developpement-dun-nouveau-vaccin-prophylactique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unither-pharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"D\u00e9veloppement d\u2019un nouveau vaccin prophylactique"}]},{"@type":"WebSite","@id":"https:\/\/www.unither-pharma.com\/fr\/#website","url":"https:\/\/www.unither-pharma.com\/fr\/","name":"Unither","description":"","publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.unither-pharma.com\/fr\/#organization","name":"Unither","url":"https:\/\/www.unither-pharma.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","width":514,"height":252,"caption":"Unither"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/UnitherPharma","https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/","https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA"]},{"@type":"Person","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/person\/eb53be7b5e854190989b3a8783d0cc28","name":"admin","sameAs":["https:\/\/www.unither-pharma.com"],"url":"https:\/\/www.unither-pharma.com\/fr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/comments?post=26678"}],"version-history":[{"count":2,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26678\/revisions"}],"predecessor-version":[{"id":26937,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/26678\/revisions\/26937"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media\/20110"}],"wp:attachment":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=26678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/categories?post=26678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/tags?post=26678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}